RTW INVESTMENTS, LP - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$73,505,075
-34.5%
7,136,415
+4.8%
1.55%
-27.4%
Q2 2023$112,239,364
+113.4%
6,810,641
+18.6%
2.14%
+95.2%
Q1 2023$52,596,161
+27.9%
5,741,9390.0%1.10%
+30.5%
Q4 2022$41,112,283
+42.9%
5,741,9390.0%0.84%
+26.5%
Q3 2022$28,767,000
+105.3%
5,741,9390.0%0.66%
+83.1%
Q2 2022$14,010,000
-64.3%
5,741,9390.0%0.36%
-55.4%
Q1 2022$39,217,000
-15.5%
5,741,9390.0%0.81%
+19.9%
Q4 2021$46,395,000
-17.6%
5,741,9390.0%0.68%
-20.3%
Q3 2021$56,271,000
+45.6%
5,741,9390.0%0.85%
+45.6%
Q2 2021$38,643,000
-25.6%
5,741,9390.0%0.58%
-28.0%
Q1 2021$51,907,000
+44.2%
5,741,939
+6.6%
0.81%
+34.1%
Q4 2020$35,989,000
+33.1%
5,387,513
+0.4%
0.60%
-7.2%
Q3 2020$27,048,000
-36.9%
5,366,705
+1.1%
0.65%
-46.0%
Q2 2020$42,877,000
+18.3%
5,306,570
+14.9%
1.21%
-22.7%
Q1 2020$36,253,000
+41.2%
4,616,570
+35.7%
1.56%
+61.1%
Q4 2019$25,681,0003,401,4340.97%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,305,017$18,625,0007.73%
COWEN AND COMPANY, LLC 3,732,778$30,161,0002.74%
GENDELL JEFFREY L 2,446,299$19,766,0001.60%
Asymmetry Capital Management, L.P. 369,134$2,983,0001.58%
Vivo Capital, LLC 2,937,093$23,732,0001.43%
Samsara BioCapital, LLC 659,409$5,328,0001.03%
Altium Capital Management LP 440,589$3,560,0000.98%
Knott David M Jr 258,198$2,086,0000.71%
RTW INVESTMENTS, LP 5,741,939$46,395,0000.68%
FRAZIER MANAGEMENT LLC 951,814$7,691,0000.59%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders